new post
StocksRunner logo
mail
search
 
menu
 
Novo Nordisk A/S
$48.24
-1.83%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

NVO Stock Analysis & IQ Rating | Novo Nordisk A/S

 
 
 

NVONVO Badge

 

Novo Nordisk A/S

$48.24

 
-$0.92 | -1.83%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$112.52
 
 
MKT CAP
$164.47B
 
52W Low
$45.05
 
 
VOL
$10.29M
 
P/E Ratio
13.28
 
 
AVG VOL
$15.64M
 
RSI
38.24
 
 
TREND
Downtrend
 
 
 

Latest Comments

 
 
StocksRunner
 
$NVO bouncing off support at $46.51, RSI climbing from 21.61 Metsera drama sparked a pop! Watch $49.32 for next move

November 11, 2025 01:40 PM

 
 
 
 

NVO Stock IQ

 
lock  Login to see Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

NVO Target Price

 
 
 

Strengths

 

NVO Rewards

 Trading below its fair value

NVO Rewards

 Upgraded on attractively valued

NVO Rewards

 Investors confidence is positive

 
 

Chart

 
 

$55.74   (-13.46%)

$56.98   (-15.34%)

$67.7   (-28.74%)

$106.8   (-54.83%)

 
 
1year
6month
3month
1month
 

NVO Risk Level

 

NVO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 Investors losing confidence

 
 
NVO Risk Level
Low
LOW
HIGH
 

NVO Analysts Opinion

 

NVO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

NVO Earnings Sentiment

 Below analyst estimate

NVO Earnings Sentiment

 Earnings increase YoY

 
 

Rating

×
 

Rating

 

NVO Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

NVO Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 

NVO Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

NVO Future Sentiment

 Trading below its fair value

 
 

NVO Analysts Opinion

NVO Analysts opinion is negative and it remained unchanged from the past 3 months

 

NVO Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
78%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
25%
56%
86%
 

NVO Street Sentiment 

NVO Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

NVO Performance Sentiment

 
Sentiments overview associated with NVO events and the stock performance.
 
78%
19%
Positive
Negative
84 out of 108
events present
21 out of 108
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$50.26
 
Resistance
Price
 
$45.68
 
 
Current Price Range
 
$61.85
 
 
Show methods +
 
 
NVO Latest Analysis +
 
 
FAQ About NVO Stock Insights
 

What is NVO current stock price?

What are NVO stock strengths?

What is NVO Risk Level?

What is NVO market cap and volume?

What is NVO current Stock IQ?

Should I buy NVO stock right now?

Is NVO a Strong Buy right now?

What does a 'Strong Buy' rating mean for NVO?

What does a 'Strong Sell' rating mean for NVO?

What factors influence NVO's Stock IQ?

 
 
StocksRunner

Explore our NVO Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored NVO Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our NVO Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 

NVO NVO Badge

 

Novo Nordisk A/S

 
 

Current Price

 

$48.24

 
-$0.92 | -1.83%
 
 
52W High
$112.52
 
 
MKT CAP
$164.47B
 
52W Low
$45.05
 
 
VOL
$10.29M
 
P/E Ratio
13.28
 
 
AVG VOL
$15.64M
 
RSI
38.24
 
 
TREND
Downtrend
 
 
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

NVO Rewards

 Trading below its fair value

NVO Rewards

 Upgraded on attractively valued

NVO Rewards

 Investors confidence is positive

 
 
 
 
user
 
 
 
 

Latest Comments

 
 
StocksRunner
 
$NVO bouncing off support at $46.51, RSI climbing from 21.61 Metsera drama sparked a pop! Watch $49.32 for next move

November 11, 2025 01:40 PM

 
 
 
 
 
 
 

NVO Stock IQ

 
lock  Login to unlock Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$55.74   (-13.46%)

$56.98   (-15.34%)

$67.7   (-28.74%)

$106.8   (-54.83%)

 
 
1year
6month
3month
1month
 

NVO Analysts Opinion

 

NVO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

NVO Earnings Sentiment

 Below analyst estimate

NVO Earnings Sentiment

 Earnings increase YoY

 
 

Rating

×
 

Rating

 

NVO Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

NVO Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 

NVO Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

NVO Future Sentiment

 Trading below its fair value

 
 

NVO Analysts Opinion

NVO Analysts opinion is negative and it remained unchanged from the past 3 months

 

NVO Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
78%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
25%
56%
86%
 

NVO Street Sentiment 

NVO Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

NVO Risk Level

 

NVO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 

 Investors losing confidence

 
 
NVO Risk Level
Low
LOW
HIGH
 
NVO Performance Sentiment
 
Sentiments overview associated with NVO events and the stock performance.
 
78%
19%
Positive
Negative
84 out of 108
events present
21 out of 108
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$50.26
 
Resistance
Price
 
$45.68
 
 
Current Price Range
 
$61.85
 
 
Show methods +
 
 
 
 
 
 

NVO Latest Analysis

 
 
 

Is It Too Late to Buy Novo Nordisk After the Drop?. Novo Nordisk (NYSE: NVO) is in the spotlight after cutting guidance again but analysts remain optimistic. With Ozempic and Wegovy driving strong sales and a 52% upside potential this could be one of the best comeback stories in pharma.

 

Fri Nov 14, 2025

$48.24 | -1.83%
 
Activity
Potential

Team Novo Nordisk announce extended partnership with Novo Nordisk for five additional years. The world'.s first all-diabetes professional cycling team will partner with Global healthcare leader through 2031 announced on World Diabetes DayTeam Novo Nordisk today announced a five-year extension of its partnership with global healthcare leader Novo Nordisk continuing the successful collaboration that led to the creation of the world'.s first all-diabetes professional cycling team. The curr

 

Fri Nov 14, 2025

$48.24 | -1.83%
 
Activity

Resolutions from the Extraordinary General Meeting of Novo Nordisk A/S. Bagsværd Denmark 14 November 2025 - Today Novo Nordisk A/S held its Extraordinary General Meeting which was convened to elect new members of the Board of Directors.

 

Fri Nov 14, 2025

$48.24 | -1.83%
 
Activity

Why Is Everyone Talking About Novo Nordisk Stock?. Key PointsNovo Nordisks latest quarterly update disappointed investors -- again.

 

Fri Nov 14, 2025

$48.24 | -1.83%
 
Activity
Activity

RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugs. Robert F. Kennedy Jr. the health secretary appearing in the Oval Office on Nov. 6 with other health officials the chief executives of Novo Nordisk and Eli Lilly and others.

 

Fri Nov 14, 2025

$48.24 | -1.83%
 
Activity

Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs. Robert F. Kennedy Jr. the health secretary appearing in the Oval Office on Nov. 6 with other health officials the chief executives of Novo Nordisk and Eli Lilly and others.

 

Fri Nov 14, 2025

$48.24 | -1.83%
 
Activity

Novo Nordisks leadership strategy tested as shareholders signal frustration ahead of vote on board revamp. Novo Nordisk has found itself in an increasingly chaotic situation as of late with shares plunging and investor confidence waning.

 

Fri Nov 14, 2025

$48.24 | -1.83%
 
Activity

Novo Nordisk A/S: Candidate for the Board of Directors will not seek election. Today it was announced that Mikael Dolsten will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November

 

Thu Nov 13, 2025

$49.16 | -2.21%
 
Activity

Novo Nordisk: Long-Term Brand Dominance At A Bargain.

 

Thu Nov 13, 2025

$49.16 | -2.21%
 
Potential

WeightWatchers to offer Novo Nordisks Wegovy pill after 2026 launch. WeightWatchers CEO said it plans to offer Novo Nordisks much-anticipated Wegovy in pill form if it is launched next year in the United States.

 

Thu Nov 13, 2025

$49.16 | -2.21%
 
Activity

 
 
 
 
 
StocksRunner

Discover NVO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of NVO. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our NVO Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVO Stock trends

NVO Stock performance

NVO Stock analysis

NVO investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

NVO Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
 
×
 
0/666
joker
 
Post
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing NVO

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing NVO

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.